Pascal Ferré

Pascal Ferré

Auto-generated profile, based on publicly available information

Pascal Ferré

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, 75006 Paris, France

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2002 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TYT. Yamauchi
T. Yamauchi
JKJ. Kamon
J. Kamon
YMY. Minokoshi
Y. Minokoshi
YIY. Ito
Y. Ito
HWH. Waki
H. Waki
TKT. Kadowaki
T. Kadowaki

17 March 2004 in Nature
Verified
Journal Article
Closed access
PDF file
YMYasuhiko Minokoshi
Yasuhiko Minokoshi
TAThierry Alquier
Thierry Alquier
NFNoboru Furukawa
Noboru Furukawa
YKYoung-Bum Kim
Young-Bum Kim
ALAnna Lee
Anna Lee
BKBarbara B. Kahn
Barbara B. Kahn

1 November 2004 in Biochimie
Verified
Journal Article
Closed access
DEDelphine Eberlé
Delphine Eberlé
BHBronwyn Hegarty
Bronwyn Hegarty
PBPascale Bossard
Pascale Bossard
PFPascal Ferré
Pascal Ferré
FFFabienne Foufelle
Fabienne Foufelle

1 October 2010 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
PFP. Ferré
P. Ferré
FFFabienne Foufelle
Fabienne Foufelle

1 May 2009 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HKHélène L. Kammoun
Hélène L. Kammoun
HCHervé Chabanon
Hervé Chabanon
IHIsabelle Hainault
Isabelle Hainault
SLSerge Luquet
Serge Luquet
CMChristophe Magnan
Christophe Magnan
FFFabienne Foufelle
Fabienne Foufelle
Hepatic steatosis is present in insulin-resistant obese rodents and is concomitant with active lipogenesis. Hepatic lipogenesis depends on the insulin-induced activation of the transcription factor SREBP-1c. Despite prevailing insulin resistance, SREBP-1c is activated in the livers of genetically and diet-induced obese rodents. Recent studies have reported the presence of an ER stress response in the livers of obese ob/ob mice. To assess whether ER stress promotes SREBP-1c activation and thus contributes to lipogenesis, we overexpressed the chaperone glucose-regulated protein 78 (GRP78) in the livers of ob/ob mice using an adenoviral vector. GRP78 overexpression reduced ER stress markers and inhibited SREBP-1c cleavage and the expression of SREBP-1c and SREBP-2 target genes. Furthermore, hepatic triglyceride and cholesterol contents were reduced, and insulin sensitivity improved, in GRP78-injected mice. These metabolic improvements were likely mediated by restoration of IRS-2 expression and tyrosine phosphorylation. Interestingly, GRP78 overexpression also inhibited insulin-induced SREBP-1c cleavage in cultured primary hepatocytes. These findings demonstrate that GRP78 inhibits both insulin-dependent and ER stress–dependent SREBP-1c proteolytic cleavage and explain the role of ER stress in hepatic steatosis in obese rodents.

1 February 2004 in Diabetes
Verified
Journal Article
Closed access
PDF file
PFPascal Ferré
Pascal Ferré
Peroxisome proliferator-activated receptors (PPARs) are transcription factors belonging to the superfamily of nuclear receptors. Three isoforms (α, δ, and γ) have been described. They act on DNA response elements as heterodimers with the nuclear retinoic acid receptor. Their natural activating ligands are fatty acids and lipid-derived substrates. PPAR-α is present in liver, heart, and, to a lesser extent, skeletal muscle. When activated, it promotes fatty acid oxidation, ketone body synthesis, and glucose sparing. Fibrates, which are used as hypolipidemic drugs, are ligands of PPAR-α. PPAR-δ is ubiquitous and could also favor fatty acid oxidation in tissues in which PPAR-α is absent or less expressed. PPAR-γ is expressed in adipose tissue, lower intestine, and cells involved in immunity. Activation of PPAR-γ induces the differentiation of preadipocytes into adipocytes and stimulates triglyceride storage. Thiazolidinediones are compounds used as hypoglycemic, muscle insulin-sensitizing agents in type 2 diabetes. Unexpectedly, they are activators of PPAR-γ. Their action on muscle insulin sensitivity may be secondary to the lowering of circulating lipids on PPAR-γ activation and to the secretion by adipocytes of insulin-sensitizing hormones such as adiponectin, all promoting glucose utilization. The PPARs are thus major regulators of lipid and glucose metabolism, allowing adaptation to the prevailing nutritional environment.